A Strategic Approach to Positioning of Cytochrome P450 Studies and Risk Assessment for Drug-Drug Interaction in Drug Discovery

被引：0
|
作者：
Yasuhiro, Yamada [1 ]
机构：
[1] Mitsubishi Tanabe Pharma Corp, DMPK Res Lab, Toda, Saitama 3358505, Japan
来源：
16TH INTERNATIONAL CONFERENCE ON CYTOCHROME P450, PROCEEDINGS | 2009年
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：7 / 11
页数：5
相关论文
共 50 条
  • [31] Cytochrome P450 3A and P-glycoprotein drug-drug interactions with voclosporin
    Ling, Spencer Y.
    Huizinga, Robert B.
    Mayo, Patrick R.
    Larouche, Richard
    Freitag, Derrick G.
    Aspeslet, Launa J.
    Foster, Robert T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (06) : 1039 - 1050
  • [32] Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development
    Rao Gajula, Siva Nageswara
    Pillai, Megha Sajakumar
    Samanthula, Gananadhamu
    Sonti, Rajesh
    BIOANALYSIS, 2021, 13 (17) : 1355 - 1378
  • [33] Drug-drug interactions of cytochrome P450 3A4 studied by electrochemistry
    Sadeghi, S.
    Ferreo, S.
    DiNardo, G.
    Gilardi, G.
    FEBS JOURNAL, 2008, 275 : 371 - 371
  • [34] Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450
    Gubbins, Paul O.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (11) : 1411 - 1429
  • [35] The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions
    Obach, RS
    Walsky, RL
    Venkatakrishnan, K
    Gaman, EA
    Houston, JB
    Tremaine, LM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01): : 336 - 348
  • [36] Quantitative prediction of intravenous drug-drug interactions mediated by cytochrome P450 perpetrators
    Tuloup, V.
    Tod, M.
    Bourguignon, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 25 - 25
  • [37] Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes
    Tanaka, E
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1998, 23 (06) : 403 - 416
  • [38] In vitro drug-drug interaction screens for canine veterinary medicines: Evaluation of cytochrome P450 reversible inhibition
    Aidasani, Divesh
    Zaya, Matthew J.
    Malpas, Phyllis B.
    Locuson, Charles W.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (08) : 1512 - 1518
  • [39] Prediction of pharmacokinetic drug-drug interaction caused by changes in cytochrome P450 activity using in vivo information
    Hisaka, Akihiro
    Ohno, Yoshiyuki
    Yamamoto, Takehito
    Suzuki, Hiroshi
    PHARMACOLOGY & THERAPEUTICS, 2010, 125 (02) : 230 - 248
  • [40] Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development
    Nettleton, David O.
    Einolf, Heidi J.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (04) : 382 - 403
12345